Sign In
Buy BPTH
$0.0300
+0.0066 (+28.21%)
At Close: Jun 03, 2026
Bio-Path Holdings to Announce Second Quarter 2021 Financial Results on August 13, 2021
07:00am, Friday, 06'th Aug 2021
HOUSTON, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a po
Why Moderna, Bio-Path Holdings And vTv Therapeutics Are Moving Today
10:45am, Tuesday, 22'nd Jun 2021
Moderna, Inc. (NASDAQ: MRNA), Bio-Path Holdings, Inc. (NASDAQ: BPTH) and vTv Therapeutics Inc. (NASDAQ: VTVT) are among the biggest biotech movers Tuesday. Moderna Gains On Additional EU Orders: Moder
Bio-Path Granted Key Mechanism of Action U.S. Patent for BP1003
07:00am, Tuesday, 22'nd Jun 2021
Provides Protection and Highlights Novelty of BP1003 to Inhibit STAT3 Expression in a Variety of Difficult to Treat Cancers Provides Protection and Highlights Novelty of BP1003 to Inhibit STAT3 Expres
Bio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q1 2021 Results - Earnings Call Transcript
11:46am, Friday, 14'th May 2021
Bio-Path Holdings, Inc. (BPTH) CEO Peter Nielsen on Q1 2021 Results - Earnings Call Transcript
Bio-Path Holdings Reports First Quarter 2021 Financial Results
07:00am, Friday, 14'th May 2021
Conference Call to be Held Today at 8:30 A.M. ET Conference Call to be Held Today at 8:30 A.M. ET
Bio-Path Holdings to Announce First Quarter 2021 Financial Results on May 14, 2021
07:00am, Friday, 07'th May 2021
HOUSTON, May 07, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a por
Why Acadia Pharma, Bio-path And Cidara Are Moving Today
09:48am, Monday, 05'th Apr 2021
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), Bio-Path Holdings, Inc. (NASDAQ: BPTH) and Cidara Therapeutics, Inc. (NASDAQ: CDTX) are among the early movers in the biotech space. ACADIA Wilts On FDA Rej
Bio-Path Stock Price Increased Over 15% Pre-Market: Why It Happened
08:06am, Monday, 05'th Apr 2021
The stock price of Bio-Path Holdings Inc (NASDAQ: BPTH) has increased by over 15% pre-market. This is why it happened.
Bio-Path Stock Is Trading Higher As Prexigebersen Triplet Combo Shows Favorable Safety Profile In Acute Myeloid Leukemia Study
08:03am, Monday, 05'th Apr 2021
Bio-Path Holdings Inc (NASDAQ: BPTH) has completed the safety run-in of Stage 2 of the Phase 2 study evaluating prexigebersen to treat acute myeloid leukemia (AML) in combination with frontline the
HOUSTON, April 05, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a p
Bio-Path (BPTH) Moves to Buy: Rationale Behind the Upgrade
12:53pm, Tuesday, 16'th Mar 2021
Bio-Path (BPTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Bio-Path Holdings to Present at the 2021 American Association for Cancer Research Annual Meeting
07:00am, Thursday, 11'th Mar 2021
HOUSTON, March 11, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to deve
Bio-Path Holdings, Inc (BPTH) CEO Peter Nielsen on Q4 2020 Results - Earnings Call Transcript
11:07am, Wednesday, 10'th Mar 2021
Bio-Path Holdings, Inc (BPTH) CEO Peter Nielsen on Q4 2020 Results - Earnings Call Transcript
Bio-Path Holdings Reports Full Year 2020 Financial Results
07:00am, Wednesday, 10'th Mar 2021
Conference Call to be Held Today at 8:30 A.M. ET Conference Call to be Held Today at 8:30 A.M. ET
Bio-Path Holdings to Announce Full Year 2020 Financial Results on March 10, 2021
04:01pm, Wednesday, 03'rd Mar 2021
HOUSTON, March 03, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a p
